Board Meeting Details
The Board of Directors meeting was held on 13th November 2026 from 16:30 to 19:50. The board approved three key items:
1. Unaudited Financial Results for the quarter and half year ended 30th September 2026
2. Limited Review Report from Statutory Auditors on the unaudited financial results
3. Transfer of unclaimed dividend for 2018-19 to Investor Education and Protection Fund (IEPF) and closure of unpaid dividend account with IDBI Bank Limited
Financial Results - Quarter Ended 30th September 2026
Income Statement Highlights:
- Revenue from Operations: ₹1,417.58 lakhs (vs ₹1,415.95 lakhs in Q2 FY26)
- Other Income: ₹195.33 lakhs (vs ₹264.99 lakhs in Q2 FY26)
- Total Income: ₹1,512.91 lakhs (vs ₹1,680.93 lakhs in Q2 FY26)
- Total Expenses: ₹1,454.26 lakhs (vs ₹1,475.06 lakhs in Q2 FY26)
- Profit Before Tax: ₹158.64 lakhs (vs ₹204.87 lakhs in Q2 FY26)
- Tax Expense: ₹44.69 lakhs (vs ₹52.57 lakhs in Q2 FY26)
- Net Profit After Tax: ₹113.95 lakhs (vs ₹152.30 lakhs in Q2 FY26)
- Earnings Per Share (Basic & Diluted): ₹1.11 (vs ₹1.49 in Q2 FY26)
Financial Results - Half Year Ended 30th September 2026
Income Statement Highlights:
- Revenue from Operations: ₹2,327.51 lakhs (vs ₹2,685.94 lakhs in H1 FY26)
- Other Income: ₹421.47 lakhs (vs ₹441.49 lakhs in H1 FY26)
- Total Income: ₹2,743.98 lakhs (vs ₹3,127.42 lakhs in H1 FY26)
- Total Expenses: ₹2,595.73 lakhs (vs ₹2,595.61 lakhs in H1 FY26)
- Profit Before Tax: ₹153.25 lakhs (vs ₹530.82 lakhs in H1 FY26)
- Tax Expense: ₹43.47 lakhs (vs ₹135.39 lakhs in H1 FY26)
- Net Profit After Tax: ₹109.78 lakhs (vs ₹395.42 lakhs in H1 FY26)
- Earnings Per Share (Basic & Diluted): ₹1.07 (vs ₹3.86 in H1 FY26)
Operational Details
- The company operates exclusively in one reportable business segment: APIs (Active Pharmaceutical Ingredients)
- Half-year sales include Export sales of ₹1,550.04 lakhs and Domestic sales of ₹777.47 lakhs
- Paid-up Equity Share Capital: ₹1,024.63 lakhs (Face value ₹10 per share)
Balance Sheet Position as at 30th September 2026
Assets:
- Non-Current Assets: ₹2,574.09 lakhs (including Property Plant and Equipment: ₹1,779.04 lakhs, Financial Assets: ₹749.62 lakhs)
- Current Assets: ₹12,965.49 lakhs (including Inventories: ₹1,569.24 lakhs, Trade Receivables: ₹1,953.61 lakhs, Cash and Cash Equivalents: ₹312.48 lakhs, Bank balances: ₹8,626.08 lakhs)
- Total Assets: ₹15,539.58 lakhs
Liabilities and Equity:
- Equity: ₹14,155.98 lakhs (Equity Share Capital: ₹1,024.53 lakhs, Other Equity: ₹13,131.45 lakhs)
- Non-Current Liabilities: ₹96.67 lakhs (Deferred Tax Liabilities)
- Current Liabilities: ₹1,286.93 lakhs (including Trade Payables: ₹47.91 lakhs, Other Financial Liabilities: ₹877.40 lakhs, Current Tax Liabilities: ₹24.78 lakhs)
Cash Flow Statement - Half Year Ended 30th September 2026
- Net Cash Flow from Operating Activities: ₹(213.15) lakhs
- Net Cash Flow from Investing Activities: ₹4,619.92 lakhs (mainly from Security Deposits: ₹1,326.00 lakhs and Interest from Bank Deposits: ₹308.65 lakhs)
- Net Cash Flow from Financing Activities: ₹0
- Net Increase in Cash and Cash Equivalents: ₹4,405.77 lakhs
Auditor's Limited Review Report
P.S.N Ravishanker & Associates conducted a limited review and issued a qualified opinion noting:
Qualification:
- Certain sales made on or before 30th September 2026 where control over goods had not passed to customers, contrary to Ind-AS 115
- Q2 Impact: Net Profit After Tax understated by ₹41.40 lakhs, Turnover understated by ₹146.91 lakhs
- H1 Impact: Net Profit After Tax overstated by ₹7.25 lakhs, Turnover overstated by ₹13.52 lakhs
Dividend Transfer Action
The board approved transfer of unclaimed dividend for 2018-19 to IEPF and closure of the unpaid dividend account maintained with IDBI Bank Limited.